1. Drug–Drug Interactions Between HMG-CoA Reductase Inhibitors (Statins) and Antiviral Protease Inhibitors

   • Benoit Chauvin
   • Sylvain Drouot
   • Anne-Marie Taburet

   Review Article 24 May 2013 Pages: 815 - 831

   

2. The Role of Pharmacogenetics in Drug Disposition and Response of Oral Glucose-Lowering Drugs

   • N. van Leeuwen
   • J. J. Swen
   • L. M. ’t Hart

   Review Article 30 May 2013 Pages: 833 - 854

   

3. Pharmacokinetics and Pharmacokinetic–Pharmacodynamic Correlations of Therapeutic Peptides

   • Lei Diao
   • Bernd Meibohm

   Review Article 30 May 2013 Pages: 855 - 868

   

4. Antimicrobial Treatment of Febrile Neutropenia: Pharmacokinetic–Pharmacodynamic Considerations

   • Tiphaine Goulenok
   • Bruno Fantin

   Review Article 27 June 2013 Pages: 869 - 883

5. The Relationship Between Fluticasone Furoate Systemic Exposure and Cortisol Suppression

   • Ann Allen

   Original Research Article Open access 30 May 2013 Pages: 885 - 896

   

6. Impact of Impaired Renal Function on the Pharmacokinetics of the Antiepileptic Drug Lacosamide

   • Willi Cawello
   • Uwe Fuhr
   • Atef Halabi

   Original Research Article 05 June 2013 Pages: 897 - 906

   

7. Population Pharmacokinetic Analysis for Hydrocodone Following the Administration of Hydrocodone Bitartrate Extended-Release Capsules

   • Murad R. Melhem
   • Christopher M. Rubino
   • Cynthia Y. Robinson

   Original Research Article 30 May 2013 Pages: 907 - 917